| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/04/2010 | WO2010014930A2 Therapeutic agents |
| 02/04/2010 | WO2010014611A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
| 02/04/2010 | WO2010014047A1 Process for the preparation of paliperidone |
| 02/04/2010 | WO2010013844A1 Photoelectric conversion element |
| 02/04/2010 | WO2010013595A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative |
| 02/04/2010 | WO2010012611A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
| 02/04/2010 | WO2010012397A1 N-(indol-3-ylalkyl)(hetero)arylamide derivatives as modulators of the ep2 receptor |
| 02/04/2010 | WO2010012138A1 7-[4-(aminomethyl)-4-fluoro-3-(alkoxyimino)pyrrolidin-1-yl] quinoline carboxylic acid derivatives and methods for preparation |
| 02/04/2010 | WO2010012106A1 Selective glycosidase inhibitors and uses thereof |
| 02/04/2010 | WO2009150139A3 Indolyl-pyridazinyl-diazabicyclononane derivatives in labelled and unlabelled form and their use in diagnostic methods |
| 02/04/2010 | WO2009001129A9 1-cyanocyclopropyl-derivatives as cathepsin k inhibitors |
| 02/04/2010 | US20100029943 Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone |
| 02/04/2010 | US20100029911 Method For Solid-Phase Peptide Synthesis And Purification |
| 02/04/2010 | US20100029710 COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARy ACTIVATING ACTIVITIES |
| 02/04/2010 | US20100029708 Compounds and compositions for treatment of cancer |
| 02/04/2010 | US20100029701 Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/04/2010 | US20100029697 Substituted pyrido[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine derivatives as cannabinoid-1 receptor modulators |
| 02/04/2010 | US20100029694 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 02/04/2010 | US20100029643 Heterocyclyc sulfonamides having edg-1 antagonistic activity |
| 02/04/2010 | US20100029638 Fused heterocyclyc inhibitor compounds |
| 02/04/2010 | US20100029637 Chymase Inhibitors |
| 02/04/2010 | US20100029635 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agents |
| 02/04/2010 | US20100029634 Chemokine Receptor Modulators |
| 02/04/2010 | US20100029633 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors |
| 02/04/2010 | US20100029629 Acyclic compounds having 5-ht6 receptor affinity |
| 02/04/2010 | US20100029619 Fused heterocyclic compound |
| 02/04/2010 | US20100029616 Urotensin ii receptor antagonists |
| 02/04/2010 | US20100029540 Biheteroaryl metal complexes as bleach catalysts |
| 02/04/2010 | US20100028301 IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT |
| 02/04/2010 | US20100028299 Methods and compositions of treating a flaviviridae family viral infection |
| 02/04/2010 | CA2732628A1 Therapeutic agents |
| 02/04/2010 | CA2732335A1 Selective glycosidase inhibitors and uses thereof |
| 02/04/2010 | CA2731358A1 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 02/04/2010 | CA2731323A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
| 02/04/2010 | CA2729045A1 Pyrimidine compounds, compositions and methods of use |
| 02/04/2010 | CA2728096A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
| 02/03/2010 | EP2149571A1 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position |
| 02/03/2010 | EP2149551A1 N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors |
| 02/03/2010 | EP2149370A1 Diazabicyclic compounds and microemulsions thereof |
| 02/03/2010 | EP2148877A2 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 02/03/2010 | EP2148862A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk |
| 02/03/2010 | EP2148857A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists |
| 02/03/2010 | EP1730147B1 Substituted 1,4,8-triazaspiro[4,5]decan-2-on compounds for use in the treatment of obesity |
| 02/03/2010 | EP1511742B1 Kinase inhibitors |
| 02/03/2010 | CN101641357A 4-substituted azaadamantane derivatives and methods of use thereof |
| 02/03/2010 | CN101641356A Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof |
| 02/03/2010 | CN101641355A Azaadamantane ester and carbamate derivatives and methods of use thereof |
| 02/03/2010 | CN101641354A Novel heteroaryl substituted imidazo [1,2 -a] pyridine derivatives |
| 02/03/2010 | CN101641352A Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof |
| 02/03/2010 | CN101641351A Compounds and methods for kinase modulation, and indications therefor |
| 02/03/2010 | CN100586949C Method for producing quaterrylene-3,4:13,14-tetracarboxy diimides by direct synthesis |
| 02/02/2010 | US7655800 Crystalline 1H-imidazo[4,5-b]pyridin-5-amine, 7-[5-[(cyclohexylmethylamino)-methyl]-1H-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses |
| 02/02/2010 | US7655795 (3R,4R)-1-[(9-deazahypoxanthin-9-yl)methyl]-3-hydroxy-4-hydroxymethyl-pyrrolidine; reaction of formaldehydewith a cyclic amine and a heteroaromatic compound to give methylene linked cyclic amine deazapurines; cancer, bacterial, protozoal infections or T-cell mediated diseases |
| 02/02/2010 | US7655690 1-sulfonylindole derivatives, their preparation and their use as 5-HT6 ligands |
| 02/02/2010 | US7655684 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 02/02/2010 | US7655670 1-((tetrahydropyran-2-yl)oxy-ethyl)-5-tert-butoxycarbonyl-spiro[indoline-3,4'-piperidin]-2-one; ORL-1 (orphan opioid receptor) G-protein coupled receptor; brain, psychological disorders |
| 02/02/2010 | US7655665 Nitromethylene derivatives and their use |
| 02/02/2010 | US7655654 Tetrazole substituted quinazoline compounds for antiproliferation agents |
| 02/02/2010 | US7655650 Oxadiazine derivatives |
| 02/02/2010 | US7655640 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin |
| 02/02/2010 | CA2485685C Calcium receptor modulating agents |
| 02/02/2010 | CA2390858C N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
| 02/02/2010 | CA2345838C Method for the synthesis of radiolabeled compounds |
| 02/02/2010 | CA2316172C Indole derivatives as inhibitors of factor xa |
| 01/31/2010 | CA2674011A1 Pharmaceutical compounds |
| 01/31/2010 | CA2674006A1 Microemulsions |
| 01/28/2010 | WO2010011959A1 Antiviral compounds |
| 01/28/2010 | WO2010011772A2 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 01/28/2010 | WO2010011768A1 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 01/28/2010 | WO2010011762A1 Pyrazolopyridine kinase inhibitors |
| 01/28/2010 | WO2010011756A1 Pyrazolopyridine kinase inhibitors |
| 01/28/2010 | WO2010011546A2 Acyclic compounds having 5-ht6 receptor affinity |
| 01/28/2010 | WO2010010191A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases. |
| 01/28/2010 | WO2010010190A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/28/2010 | WO2010010189A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/28/2010 | WO2010010188A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases. |
| 01/28/2010 | WO2010010187A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/28/2010 | WO2010010186A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/28/2010 | WO2010010184A1 [1, 2, 4] triazolo [1, 5-a] pyridines as jak inhibitors |
| 01/28/2010 | WO2009147237A9 Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics |
| 01/28/2010 | WO2009107850A3 Fused heterocyclic derivative and use thereof |
| 01/28/2010 | US20100022580 New 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indole compounds and methods of use thereof |
| 01/28/2010 | US20100022573 Inhibitors of akt activity |
| 01/28/2010 | US20100022571 Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors |
| 01/28/2010 | US20100022548 Use of n-heterocyclylmethylbenzamides in therapeutics |
| 01/28/2010 | US20100022531 Novel compounds as p2x7 modulators and uses thereof |
| 01/28/2010 | US20100022524 Tricyclic tetrahydroquinoline antibacterial agents |
| 01/28/2010 | US20100022522 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 01/28/2010 | US20100022521 Compounds |
| 01/28/2010 | US20100022516 4,5-Disubstituted-2-aryl pyrimidines |
| 01/28/2010 | US20100022514 Heterocycle Compounds and Methods of Use Thereof |
| 01/28/2010 | US20100022508 Antiviral compounds |
| 01/28/2010 | US20100022506 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 01/28/2010 | US20100022500 Macrocyclic Lactams and Pharmaceutical Use Thereof |
| 01/28/2010 | US20100022021 New azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions |
| 01/28/2010 | US20100021458 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/28/2010 | US20100021394 High penetration prodrug compositions of 1h-imidazo[4,5-c]quinolin-4-amines and 1h-imidazo[4,5-c]quinolin-4-amine-related compounds |
| 01/28/2010 | US20100019670 Organic electroluminescent device and platinum compound |
| 01/28/2010 | CA2731498A1 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 01/28/2010 | CA2731496A1 Pyrazolopyridine kinase inhibitors |